Methyldopate is primarily used in the treatment of hypertension, particularly in cases where rapid blood pressure control is necessary. It is often administered intravenously in clinical settings to manage hypertensive emergencies, such as severe high blood pressure during pregnancy (preeclampsia or eclampsia). The compound works by being metabolized into methyldopa, which then acts on the central nervous system to reduce sympathetic outflow, leading to vasodilation and decreased blood pressure. Its rapid onset of action makes it a valuable option in acute scenarios where immediate blood pressure reduction is critical to prevent organ damage. Additionally, it is considered safe for use in pregnant women, making it a preferred choice in obstetric care for managing hypertension-related complications.